These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 32170564)

  • 1. Evaluation of the histological variability of core and wedge biopsies in nonalcoholic fatty liver disease in bariatric surgical patients.
    Ooi GJ; Clouston A; Johari Y; Kemp WW; Roberts SK; Brown WA; Burton PR
    Surg Endosc; 2021 Mar; 35(3):1210-1218. PubMed ID: 32170564
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlation of paired liver biopsies in morbidly obese patients with suspected nonalcoholic fatty liver disease.
    Merriman RB; Ferrell LD; Patti MG; Weston SR; Pabst MS; Aouizerat BE; Bass NM
    Hepatology; 2006 Oct; 44(4):874-80. PubMed ID: 17006934
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Histopathologic variability between the right and left lobes of the liver in morbidly obese patients undergoing Roux-en-Y bypass.
    Larson SP; Bowers SP; Palekar NA; Ward JA; Pulcini JP; Harrison SA
    Clin Gastroenterol Hepatol; 2007 Nov; 5(11):1329-32. PubMed ID: 17702661
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Histopathology of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis.
    Takahashi Y; Fukusato T
    World J Gastroenterol; 2014 Nov; 20(42):15539-48. PubMed ID: 25400438
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-Throughput, Machine Learning-Based Quantification of Steatosis, Inflammation, Ballooning, and Fibrosis in Biopsies From Patients With Nonalcoholic Fatty Liver Disease.
    Forlano R; Mullish BH; Giannakeas N; Maurice JB; Angkathunyakul N; Lloyd J; Tzallas AT; Tsipouras M; Yee M; Thursz MR; Goldin RD; Manousou P
    Clin Gastroenterol Hepatol; 2020 Aug; 18(9):2081-2090.e9. PubMed ID: 31887451
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Utility of transient elastography (fibroscan) and impact of bariatric surgery on nonalcoholic fatty liver disease (NAFLD) in morbidly obese patients.
    Garg H; Aggarwal S; Shalimar ; Yadav R; Datta Gupta S; Agarwal L; Agarwal S
    Surg Obes Relat Dis; 2018 Jan; 14(1):81-91. PubMed ID: 29126863
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Non-alcoholic fatty liver disease - histological scoring systems: a large cohort single-center, evaluation study.
    Rastogi A; Shasthry SM; Agarwal A; Bihari C; Jain P; Jindal A; Sarin S
    APMIS; 2017 Nov; 125(11):962-973. PubMed ID: 29076589
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suboptimal reliability of liver biopsy evaluation has implications for randomized clinical trials.
    Davison BA; Harrison SA; Cotter G; Alkhouri N; Sanyal A; Edwards C; Colca JR; Iwashita J; Koch GG; Dittrich HC
    J Hepatol; 2020 Dec; 73(6):1322-1332. PubMed ID: 32610115
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development and Validation of a Novel Scoring System for Noninvasive Nonalcoholic Steatohepatitis Detection in Bariatric Patients.
    Billeter AT; Wloka S; Behnisch R; Albrecht T; Roessler S; Goeppert B; Mueller S; Nickel F; Müller B
    Obes Facts; 2021; 14(5):490-500. PubMed ID: 34419953
    [TBL] [Abstract][Full Text] [Related]  

  • 10. qFIBS: An Automated Technique for Quantitative Evaluation of Fibrosis, Inflammation, Ballooning, and Steatosis in Patients With Nonalcoholic Steatohepatitis.
    Liu F; Goh GB; Tiniakos D; Wee A; Leow WQ; Zhao JM; Rao HY; Wang XX; Wang Q; Wan WK; Lim KH; Romero-Gomez M; Petta S; Bugianesi E; Tan CK; Harrison SA; Anstee QM; Chang PJ; Wei L
    Hepatology; 2020 Jun; 71(6):1953-1966. PubMed ID: 31600834
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Laparoscopic Sleeve Gastrectomy on the Horizon as a Promising Treatment Modality for NAFLD.
    Salman MA; Salman AA; Abdelsalam A; Atallah M; Shaaban HE; El-Mikkawy A; Omar MG; Elshenoufy M
    Obes Surg; 2020 Jan; 30(1):87-95. PubMed ID: 31372873
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bariatric Surgery in Nonalcoholic Fatty Liver Disease (NAFLD): Impact Assessment Using Paired Liver Biopsy and Fibroscan.
    Agarwal L; Aggarwal S; Shalimar ; Yadav R; Dattagupta S; Garg H; Agarwal S
    Obes Surg; 2021 Feb; 31(2):617-626. PubMed ID: 33052552
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Benefit-risk of intraoperative liver biopsy during bariatric surgery: review and perspectives.
    Barbois S; Arvieux C; Leroy V; Reche F; Stürm N; Borel AL
    Surg Obes Relat Dis; 2017 Oct; 13(10):1780-1786. PubMed ID: 28935200
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Histopathological stages of nonalcoholic fatty liver disease in type 2 diabetes: prevalences and correlated factors.
    Leite NC; Villela-Nogueira CA; Pannain VL; Bottino AC; Rezende GF; Cardoso CR; Salles GF
    Liver Int; 2011 May; 31(5):700-6. PubMed ID: 21457442
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nonalcoholic fatty liver disease: different classifications concordance and relationship between degrees of morphological features and spectrum of the disease.
    Monteiro JM; Monteiro GM; Caroli-Bottino A; Pannain VL
    Anal Cell Pathol (Amst); 2014; 2014():526979. PubMed ID: 25763333
    [TBL] [Abstract][Full Text] [Related]  

  • 16. EUS-guided core liver biopsy sampling using a 22-gauge fork-tip needle: a prospective blinded trial for histologic and lipidomic evaluation in nonalcoholic fatty liver disease.
    Bazerbachi F; Vargas EJ; Matar R; Storm AC; Mounajjed TM; Topazian MD; Levy MJ; Chandrasekhara V; Abu Dayyeh BK
    Gastrointest Endosc; 2019 Dec; 90(6):926-932. PubMed ID: 31437454
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bariatric surgery improves histological features of nonalcoholic fatty liver disease and liver fibrosis.
    Taitano AA; Markow M; Finan JE; Wheeler DE; Gonzalvo JP; Murr MM
    J Gastrointest Surg; 2015 Mar; 19(3):429-36; discussion 436-7. PubMed ID: 25537957
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Histopathology of nonalcoholic fatty liver disease.
    Brunt EM; Tiniakos DG
    World J Gastroenterol; 2010 Nov; 16(42):5286-96. PubMed ID: 21072891
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Utility of Ultrasound, Transaminases, and Visual Inspection to Assess Nonalcoholic Fatty Liver Disease in Bariatric Surgery Patients.
    Petrick A; Benotti P; Wood GC; Still CD; Strodel WE; Gabrielsen J; Rolston D; Chu X; Argyropoulos G; Ibele A; Gerhard GS
    Obes Surg; 2015 Dec; 25(12):2368-75. PubMed ID: 26003548
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Wedge and needle liver biopsies show discordant histopathology in morbidly obese patients undergoing Roux-en-Y gastric bypass surgery.
    Rawlins SR; Mullen CM; Simon HM; Kim T; Landas SK; Walser MS; Levine RA
    Gastroenterol Rep (Oxf); 2013 Jul; 1(1):51-7. PubMed ID: 24759667
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.